Cleared Traditional

K873666 - PALL LEUKOCYTE REMOVAL FILTER, BLOOD

K873666 is an FDA 510(k) clearance for PALL LEUKOCYTE REMOVAL FILTER, manufactured by Pall Biomedical Products Co.. The device is a Class 2 General Hospital device with product code CAK cleared through the Traditional 510(k) pathway after a 118-day FDA review.

K873666 · Pall Biomedical Products Co. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1988
Decision
118d
Days
Class 2
Risk

K873666 is an FDA 510(k) clearance for the PALL LEUKOCYTE REMOVAL FILTER, BLOOD. Classified as Microfilter, Blood Transfusion (product code CAK), Class II - Special Controls.

Submitted by Pall Biomedical Products Co. (Glen Cove, US). The FDA issued a Cleared decision on January 6, 1988 after a review of 118 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Pall Biomedical Products Co. devices

FDA 510(k) Submission Details - K873666

510(k) Number K873666 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 10, 1987
Decision Date January 06, 1988
Days to Decision 118 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d faster than avg
Panel avg: 129d · This submission: 118d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAK Device Classification - Class 2, Special Controls

Product Code CAK Microfilter, Blood Transfusion
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - CAK Microfilter, Blood Transfusion

All 22
Devices cleared under the same product code (CAK) and FDA review panel - the closest regulatory comparables to K873666.
PALL SQ40S BLOOD FILTER (SQ40S/SQ40ST)
K960993 · Pall Biomedical Products Co. · Apr 1996
SEPACELL(R) PL-5A/10A LEUKOCYTE REMOVAL FILTERS
K904221 · Baxter Healthcare Corp · Oct 1990
SEPACELL(R) R-200/500 LEUKOCYTE REMOVAL RECIP SETS
K904223 · Baxter Healthcare Corp · Oct 1990
PALL LEUKOCYTE REMOVAL FILTER, PLATELETS
K873667 · Pall Biomedical Products Co. · Jan 1988
RESUBMITTED MICRON TRANSFUSION FILTER
K873873 · Travenol Laboratories, S.A. · Oct 1987
ERYPUR B
K864636 · Organon Teknika Corp. · Jan 1987